Oramed Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 2.34
| ORMP Stock | USD 2.34 0.03 1.30% |
Oramed |
Oramed Pharmaceuticals Target Price Odds to finish over 2.34
The tendency of Oramed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.34 | 90 days | 2.34 | about 68.69 |
Based on a normal probability distribution, the odds of Oramed Pharmaceuticals to move above the current price in 90 days from now is about 68.69 (This Oramed Pharmaceuticals probability density function shows the probability of Oramed Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Oramed Pharmaceuticals has a beta of 0.0622. This indicates as returns on the market go up, Oramed Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Oramed Pharmaceuticals will be expected to be much smaller as well. Additionally Oramed Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Oramed Pharmaceuticals Price Density |
| Price |
Predictive Modules for Oramed Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oramed Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oramed Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oramed Pharmaceuticals is not an exception. The market had few large corrections towards the Oramed Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oramed Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oramed Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.08 |
Oramed Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oramed Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oramed Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oramed Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oramed Pharmaceuticals currently holds about 133.91 M in cash with (10.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Oramed Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Oramed Pharmaceuticals Share Price Passes Below 200-Day Moving Average - Should You Sell - MarketBeat |
Oramed Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oramed Stock often depends not only on the future outlook of the current and potential Oramed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oramed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.3 M |
Oramed Pharmaceuticals Technical Analysis
Oramed Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Oramed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oramed Pharmaceuticals. In general, you should focus on analyzing Oramed Stock price patterns and their correlations with different microeconomic environments and drivers.
Oramed Pharmaceuticals Predictive Forecast Models
Oramed Pharmaceuticals' time-series forecasting models is one of many Oramed Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oramed Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oramed Pharmaceuticals
Checking the ongoing alerts about Oramed Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oramed Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oramed Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oramed Pharmaceuticals currently holds about 133.91 M in cash with (10.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Oramed Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Oramed Pharmaceuticals Share Price Passes Below 200-Day Moving Average - Should You Sell - MarketBeat |
Additional Tools for Oramed Stock Analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.